EPIGENE.COM - Trademark Details
Status: 606 - Abandoned - No Statement Of Use Filed
Serial Number
85202806
Word Mark
EPIGENE.COM
Status
606 - Abandoned - No Statement Of Use Filed
Status Date
2012-02-13
Filing Date
2010-12-21
Mark Drawing
4000 - Standard character mark
Typeset
Published for Opposition Date
2011-05-17
Law Office Assigned Location Code
M50
Employee Name
KHAN, ASMAT A
Statements
Goods and Services
medical diagnostic and therapeutic preparations, all for administration via diverse routes of administration including through the respiratory airways, and, medical devices for administering the pharmaceuticals, sold filled, the preparations including nucleotides, proteins and organic molecules for medical use, including macromolecules such as anti-sense oligonucleotides and enzymes and small and inorganic molecules for treatment of human and non-human animal respiratory, central nervous system, neoplastic, endocrine, immune and cardiovascular ailments, including bronchoconstriction, difficult breathing, impeded and obstructed lung airways, allergy(ies) and/or inflammation, which in some cases are adenosine receptor associated symptoms; pharmaceutical preparations for testing, and preventing and therapeutically treating respiratory, airway and pulmonary diseases and conditions, such as asthma, pulmonary vasoconstriction, inflammation, allergies, impeded respiration, acute respiratory disease syndrome (ards), renal damage and failure, ischemia resulting from the administration of certain drugs, including adenosine and other drugs for, for example, treating supra ventricular tachycardia (svt), adenosine stress tests, infantile respiratory distress syndrome (infantile rds), pain, cystic fibrosis, allergic rhinitis, allergic bronchitis, pulmonary hypertension, pulmonary vasconcontriction, emphysema, chronic obstructive pulmonary disease (copd), as well as cancers including leukemias, lymphomas, carcinomas, and the like, e.g., colon cancer, breast cancer, lung cancer, pancreatic cancer, hepatocellular carcinoma, kidney cancer, melanoma, etc, as well as metastatic cancers, e.g., cancers which metastasized to the lung(s), breast, liver and prostate
Pseudo Mark
EPIGENESIS
Classification Information
International Class
5 - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes
006, 018, 044, 046, 051, 052
Class Status Code
6 - Active
Class Status Date
2010-12-30
Primary Code
005
Correspondences
Name
Epigenesis Pharmaceuticals, LLC
Address
Please log in with your Justia account to see this address.
Trademark Events
Event Date | Event Description |
2010-12-24 | NEW APPLICATION ENTERED IN TRAM |
2010-12-30 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM |
2010-12-31 | NOTICE OF PSEUDO MARK MAILED |
2011-03-21 | ASSIGNED TO EXAMINER |
2011-03-29 | EXAMINERS AMENDMENT -WRITTEN |
2011-03-29 | EXAMINERS AMENDMENT E-MAILED |
2011-03-29 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
2011-03-29 | EXAMINER'S AMENDMENT ENTERED |
2011-03-29 | APPROVED FOR PUB - PRINCIPAL REGISTER |
2011-04-09 | ASSIGNED TO LIE |
2011-04-09 | LAW OFFICE PUBLICATION REVIEW COMPLETED |
2011-05-05 | TEAS WITHDRAWAL OF ATTORNEY RECEIVED |
2011-05-05 | WITHDRAWAL OF ATTORNEY GRANTED |
2011-05-17 | PUBLISHED FOR OPPOSITION |
2011-05-18 | NOTICE OF PUBLICATION |
2011-07-12 | NOA MAILED - SOU REQUIRED FROM APPLICANT |
2011-07-22 | UNDELIVERABLE MAIL - NO ACTION TAKEN |
2011-07-26 | UNDELIVERABLE MAIL - NO ACTION TAKEN |
2012-02-13 | ABANDONMENT - NO USE STATEMENT FILED |
2012-02-13 | ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED |
2012-03-09 | UNDELIVERABLE MAIL - NO ACTION TAKEN |